One of the central methods through which tumors resist elimination by endogenous tumor-specific T cells is upregulation of PD-L1 expression, since PD-L1 suppresses T-cell migration/proliferation and also restricts cancer cell killing by prevention of binding to T-cell receptors [12, 13]. The gene discussed is CD274; the disease is cancer.